The acute glucose-lowering effect of metfomin in patients with type 2 diabetes is partly glucagon-like peptide-1-dependentM. Hansen,E. Bahne,D. P. Sonne,J. F. Rehfeld,J. J. Holst, T. Vilsboll,F. K. KnopDIABETOLOGIA(2015)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要